ANFARM HELLAS S.A.

About ANFARM HELLAS S.A.


Anfarm is a leading EU GMP Pharmaceuticals Manufacturer established in 1967, engaged in the development, production, licensing & sales of quality generic pharmaceuticals on a global scale. 
Our main activities include:
1. Licensing out & International Sales   
2. Tech Transfer & Contract Manufacturing3. Contract Development
4. New Product Development
5. Development / Optimization of Lyophilization Cycles  
6. Regulatory Affairs Services


  • GR
  • 2015
    On CPHI since
Contact info
Meet us at

CPHI Frankfurt 2025

Messe, Frankfurt
28 Oct 2025 - 30 Oct 2025

Products from ANFARM HELLAS S.A. (37)

  • Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Product Amikacin Inj.Sol 500mg/2ml (EU CTD Available) & 1g/4ml (EU CTD Available: Q3 2021)

    Amikacin Solution for Injection 
    Reference Product: Briklin® / BRISTOL-MYERS SQUIBB
    Description: Amikacin sulfate is indicated in the short-term treatment of serious infections due to susceptible strains of Gram-negative bacteria, including Pseudomonas species,&nb...
  • Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab  (under development)

    Product Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

    Apixaban Film Coated Tablets 2.5mg & 5mg
    Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
    Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transie...
  • Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Product Azithromycin Pd.Sol.Inf 500mg/Vial (EU CTD Available)

    Azithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Zithromax® / PFIZER 
    Description: Azithromycin as powder for solution for infusion is indicated for the treatment of community-acquired pneumonia due to susceptible microorganisms in adult patients where initial intrav...
  • Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Product Brivaracetam Oral Solution 10mg/ml (EU CTD Available: Q4 2022)

    Brivaracetam 10mg/ml Oral Solution
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and children from 4 year...
  • Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Product Brivaracetam Sol. Inf 10mg/ml (5ml Vial) (EU CTD Available: Q3 2022)

    Brivaracetam 10mg/ml (5ml Vial) Solution for Injection/Infusion
    Reference Product: Briviact® / UCB
    Description: Brivaracetam is an antiepileptic agent which is indicated as adjunctive therapy in the treatment of partial onsetseizures with or without secondary generalization in adults, adolescents and...
  • Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available)

    Product Butamirate Syr 7.5mg/5ml (200ml Bottle) (EU CTD Available)

    Butamirate Syrup 7.5mg/5ml (200ml Bottle)  
    Reference Product: Sinecod ®/ NovartisDescription: Butamiratе Syrup is used for the symptomatic treatment of non-productive (dry) cough.
    Dossier Status: EU CTD Available
    Stability Studies: Zone II / Zone I...
  • Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available)

    Product Caspofungin Pd.C.So.In 50mg/Vial & 70mg/Vial (EU CTD Available)

    Caspofungin 50 & 70 mg/Vial Powder for Concentrate for Solution for Infusion
    Reference Product: Cancidas® / MSD
    Description: Antifungal, used for the treatment of invasive candidiasis in adult or pediatric patients, invasive aspergillosis in adultor pediatric patients who are refractory to or int...
  • Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

    Product Ceftaroline Fosamil Pd.C.So.In 600mg/Vial (under development)

    Ceftaroline Fosamil Powder for Concentrate for Solution for Infusion 600mg/vial
    Reference Product: Zinforo® / Pfizer
    Description: For the treatment of the following infections in neonates, infants, children, adolescents and adults, Complicated skin and soft tissue infections (cSSTI),&...
  • Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Product Ceftriaxone Ps.Inj.Sol 1g/Vial (IM, IV) (EU CTD Available)

    Ceftriaxone 1g/Vial Powder for Solution for Injection/Infusion 
    Reference Product: Farcef®  / Angelini
    Description: Ceftriaxone is a cephalosporin antibacterial indicated for the treatment of the following infections caused by susceptible isolates of the desig...
  • Cefuroxime  Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available)

    Product Cefuroxime Pd.Inj.Sol 750mg/Vial & 1.5g/Vial (EU CTD Available)

    Cefuroxime 750mg /Vial & 1.5g/Vial Powder for Solution for Injection 
    Reference Product: Zinadol® / GSK
    Description: Cefuroxime is an antibiotic used to treat certain infections caused by bacteria, including respiratory-tract infections such as tonsillitis and pharyngitis (infections...
  • Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available)

    Product Clarithromycin Pd.Sol.Inf. 500mg/Vial (EU CTD Available)

    Clarithromycin 500mg/Vial Powder for Solution for Infusion Reference Product: Klaricid® / ABBOTT
    Description: Clarithromycin has a longer serum half-life and better tissue penetration than erythromycin, allowing twice-a-day dosing for most common infections.  Clarithromycin as a powder for sol...
  • Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022)

    Product Clindamycin Solution for Injection 150mg/ml (EU CTD Available: 2022)

    Clindamycin 150mg/ml Solution for Injection (2ml & 4ml amps)  Dalacin® / PfizerDescription: Antibacterial.  Serious infections caused by susceptible Gram-positive organisms, staphylococci (both penicillinase- and non-penicillinase-producing), streptococci (except Streptococcus faecalis) ...

ANFARM HELLAS S.A. Resources (2)